Biomarker for Diabetes

Molecular Biomarkers can be demarcated as a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play a vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications.

  • Biomarkers of vascular function in diabetes

  • Biomarkers of vascular function in diabetes

Related Conference of Biomarker for Diabetes

October 16-17, 2023

4th Asia Pacific Congress on Diabetes and Endocrinology

Vancouver, Canada
October 16-17, 2023

2nd World congress and Expo on Diabetes

Vancouver, Canada
October 21-22, 2023

4th World Summit on Diabetes Expo

New York, USA
November 13-14, 2023

3rd European Endocrinology and Diabetes Congress

Paris, France
November 16-17, 2023

7th Annual Conference on Diabetes and Endocrinology

Paris, France
November 20-21, 2023

17th European Diabetes and Endocrinology Congress

Dubai, UAE
November 22-23, 2023

19th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 27-28, 2023

27th International Conference on Diabetes, Endocrinology and Healthcare

Singapore City, Singapore
January 11-12, 2024

5th Global summit on Diabetes and Endocrinology

Dubai, UAE
February 19-20, 2024

33rd European Diabetes Congress

London, UK
March 25-26, 2024

5th Annual Conference on Diabetes

London, UK

Biomarker for Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in